cyclical stock Archives

Cabot Undervalued Stocks Advisor Special Bulletin

January 24, 2020|From Cabot Undervalued Stocks Advisor|by Crista Huff|Value Investing

Crista has updates on several portfolio stocks.
Read More

Cabot Undervalued Stocks Advisor Special Bulletin

January 23, 2020|From Cabot Undervalued Stocks Advisor|by Crista Huff|Value Investing

Let’s talk about a specific category of stocks that I like to buy after they fall from grace. These are famous stocks that don’t fall very often, but when they do, I like to snap them up because they’re almost always destined to And...
Read More

Cabot Dividend Investor Weekly Update

January 22, 2020|From Cabot Dividend Investor|by Tom Hutchinson|Dividend Stocks

Here we are in an up leg of a bull market that began three months ago. Since early October the S&P 500 has climbed 14%. With trade issues and Iran out of the headlines, the strong economy and low interest rates are driving higher...
Read More

Cabot Undervalued Stocks Advisor Special Bulletin

January 17, 2020|From Cabot Undervalued Stocks Advisor|by Crista Huff|Value Investing

This energy stock reported a fourth-quarter earnings and revenue beat.
Read More

Cabot Growth Investor 1437

From the Cabot Growth Investor 1437 issue of Cabot Growth Investor|by Mike Cintolo|Growth Stocks

Just Because It’s Unusual Doesn’t Mean It’s Wrong The year is just over two weeks old, but we’ve already been subject to the Iran attacks, a Phase 1 trade deal with China, and soon, an impeachment trial in the Senate. Accompanying those are countless pieces...
Read More

Cabot Dividend Investor Weekly Update

January 15, 2020|From Cabot Dividend Investor|by Tom Hutchinson|Dividend Stocks

The year is starting out great! There was some volatility associated with the Iran thing but it looks like that, along with trade issues, has faded from the headlines, for now.
Read More

Cabot Undervalued Stocks Advisor Special Bulletin

January 14, 2020|From Cabot Undervalued Stocks Advisor|by Crista Huff|Value Investing

This retailer presented at the January 13 ICR Conference 2020 and moves from Buy to Strong Buy.
Read More

Cabot Undervalued Stocks Advisor Special Bulletin

January 9, 2020|From Cabot Undervalued Stocks Advisor|by Crista Huff|Value Investing

The Financial Times reported this morning that this portfolio stock was in talks, in late December, to possibly be acquired by AIG, Prudential Financial Group or Prudential Financial.
Read More

Cabot Dividend Investor 120

From the Cabot Dividend Investor 120 issue of Cabot Dividend Investor|by Tom Hutchinson|Dividend Stocks

A Jewel among the Wreckage This is one tough stock picking environment. It’s obscenely late in the bull market and economic recovery with the market near an all time record high. Sure, a similar situation has existed for several years. Okay, the economy is pretty...
Read More

Cabot Small Cap Confidential 248

From the Cabot Small Cap Confidential 248 issue of Cabot Small-Cap Confidential|by Tyler Laundon|Small Cap Stocks

The Big Idea If you want to find markets where purpose-built software can make life a lot easier look no further than life sciences and high tech. Both are defined by the ever-present need to develop new products, launch them into the market, appropriately manage through...
Read More

Cabot Dividend Investor Weekly Update

January 3, 2020|From Cabot Dividend Investor|by Tom Hutchinson|Dividend Stocks

Here we are at the beginning of a new year and a new decade. A pivotal calendar turn like this is a great time to stop, get off the train, look around and see where we are, and where we might be going.
Read More

Cabot Growth Investor 1436

From the Cabot Growth Investor 1436 issue of Cabot Growth Investor|by Mike Cintolo|Growth Stocks

Happy New Year The calendar has flipped to 2020, but nothing much has changed with the market’s evidence. On a longer-term basis, most primary indicators, such as our Cabot Trend Lines and Cabot Tides, continue to look great, and we’ve written numerous times a..
Read More

Cabot Growth Investor 1435

From the Cabot Growth Investor 1435 issue of Cabot Growth Investor|by halynam|Growth Stocks

The Bull Market Rolls into 2020 First and foremost, this being our last official issue of the year, I want to wish you and yours a very Merry Christmas and Happy Holidays. We’ll have a brief, eggnog-laden update next week, along with any bulletins needed. As...
Read More

Cabot Undervalued Stocks Advisor Special Bulletin

December 19, 2019|From Cabot Undervalued Stocks Advisor|by Crista Huff|Value Investing

Crista has updates on four portfolio stocks.
Read More

Cabot Dividend Investor 1219

From the Cabot Dividend Investor 1219 issue of Cabot Dividend Investor|by Tom Hutchinson|Dividend Stocks

A Great Way to Play the Growing Marijuana Industry We are standing on the precipice of a New Year and a new decade. In a way it’s just an arbitrary date on the calendar. But new beginnings hold great promise and are an ideal to...
Read More

Cabot Undervalued Stocks Advisor Special Bulletin

December 18, 2019|From Cabot Undervalued Stocks Advisor|by Crista Huff|Value Investing

Crista has updates on three portfolio stocks.
Read More

Cabot Undervalued Stocks Advisor Special Bulletin

December 13, 2019|From Cabot Undervalued Stocks Advisor|by Crista Huff|Value Investing

One of the portfolio stocks reports good fourth-quarter results.
Read More

Cabot Dividend Investor Weekly Update

December 11, 2019|From Cabot Dividend Investor|by Tom Hutchinson|Dividend Stocks

Here we are within weeks of the end of year and the end of a decade. It is approaching the 11th year of the recovery and bull market. The S&P 500 is up 25% in 2019 and very near the all-time high. Where we...
Read More

Cabot Undervalued Stocks Advisor Special Bulletin

December 10, 2019|From Cabot Undervalued Stocks Advisor|by Crista Huff|Value Investing

One of the portfolio stocks reported third-quarter results.
Read More

Cabot Small Cap Confidential 247

From the Cabot Small Cap Confidential 247 issue of Cabot Small-Cap Confidential|by Nancy Graves|Small Cap Stocks

The Big Idea How psyched would you be if you went to your healthcare provider and they said the following: “I can make a health optimization recommendation for you, informed not only by the latest clinical trials, but also by local and regional data about like...
Read More